Nick Pizzie
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Axsome Therapeutics, Inc. (AXSM) | C.P.A., M.B.A. Chief Financial Officer | $530,000 | $3,730,519 |
| 2024 | Axsome Therapeutics, Inc. (AXSM) | C.P.A., M.B.A. Chief Financial Officer | $505,000 | $3,756,389 |
| 2023 | Axsome Therapeutics, Inc. (AXSM) | C.P.A., M.B.A. Chief Financial Officer | $485,000 | $3,565,817 |
| 2022 | Axsome Therapeutics, Inc. (AXSM) | C.P.A., M.B.A. Chief Financial Officer | $451,000 | $3,333,457 |
| 2021 | Axsome Therapeutics, Inc. (AXSM) | C.P.A., M.B.A. Chief Financial Officer | $409,000 | $4,228,710 |
| 2020 | Axsome Therapeutics, Inc. (AXSM) | C.P.A., M.B.A. Chief Financial Officer | $375,000 | $2,365,005 |
| 2019 | Axsome Therapeutics, Inc. (AXSM) | C.P.A., M.B.A. Chief Financial Officer | $325,000 | $1,569,837 |
| 2018 | Axsome Therapeutics, Inc. (AXSM) | C.P.A., M.B.A. Chief Financial Officer | $203,125 | $687,981 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.